Core Insights - The health technology sector is entering a phase of ecological integration, driven by the upgrade of consumer health demands and deep penetration of AI technology, accelerating the industry's transition from fragmented services to an integrated ecosystem [1] Group 1: Market Dynamics - On December 23, 2023, Easy Health Group successfully listed on the Hong Kong Stock Exchange with an offer price of HKD 22.68 per share, receiving a subscription rate of 1421.47 times for public offerings and 2.9 times for international placements [2] - The company's stock opened at a 120.46% increase on its first trading day, closing at HKD 55.25, representing a 143.61% rise and a market capitalization of HKD 11.402 billion [2][3] Group 2: Business Model and Growth - Easy Health Group has a solid foundation with 168.4 million registered users and leverages AI technology to create a fusion ecosystem of health services and insurance technology, achieving nearly doubled revenue growth [5] - The company provides comprehensive health solutions, addressing user needs from prevention to intervention, and has organized 1,448 early disease screening activities in 2024 [7] - The revenue from full-cycle health management services surged from 15.2% in 2022 to 76.7% in the first half of 2025, with digital marketing becoming a major growth driver [12] Group 3: User Engagement and Retention - The user base is primarily composed of individuals aged 20 to 45, with 60.4% belonging to this core demographic, which is crucial for driving health consumption upgrades [15] - The company has achieved a 92.2% retention rate for policyholders after 13 months, significantly higher than the industry average, indicating effective user engagement strategies [16] Group 4: Technological Innovation - AI technology is a core engine for growth, with Easy Health Group developing a comprehensive AIcare technology stack that enhances service efficiency and user engagement [20][21] - The company has filed for 58 patents and 39 software copyrights, strengthening its technological barriers [22] Group 5: Market Potential - The digital health market in China is projected to grow significantly, with the penetration rate expected to rise from 2.8% in 2024 to 7.1% by 2029, and the market size for digital comprehensive health services and health insurance projected to increase from CNY 236.5 billion to CNY 748.5 billion [25][27] - Easy Health Group's extensive user health data provides ample resources for AI model training, optimizing technology to enhance service efficiency and user stickiness, thereby attracting more partners and users [27] Group 6: Conclusion - The listing of Easy Health Group on the Hong Kong Stock Exchange marks a significant milestone in its development and signals the capital market's recognition of the health technology integration model [29]

Core Viewpoint - The successful IPO of Qingsong Health Group on December 23 marks a significant step in its international capital journey and validates the commercial value of its "AI + health services + insurance" closed-loop model, injecting new momentum into China's rapidly growing digital health industry [1] Group 1: Company Overview - Qingsong Health Group, established in 2014, has transformed from an insurance technology service provider to a comprehensive digital health platform integrating health management, insurance technology, and medical services [1] - The company ranks 10th in the domestic digital comprehensive health services and health insurance services market, and 7th in the digital health services market as of 2024 [1] Group 2: Financial Performance - The company reported a revenue growth of 92.9% to 945 million yuan in 2024, achieving a substantial increase of 140% compared to 2022 [2] - For the first half of 2025, revenue further increased to 656 million yuan, reflecting a year-on-year growth of 84.7% [2] - Adjusted net profit remained above 80 million yuan for three consecutive years from 2022 to 2024, reaching 51.18 million yuan in the first half of 2025, with an 11.4% year-on-year increase [2] Group 3: Business Structure and Growth Drivers - The company has successfully transitioned from an "insurance-centric" model to one led by health services, with digital comprehensive health service revenue rising from 15.2% in 2022 to 76.7% in the first half of 2025, achieving a compound annual growth rate of 221.26% over three years [3] - The health services segment includes diverse offerings such as health content education, digital medical research assistance, comprehensive health service packages, and early disease screening promotion [3] - The insurance technology business has also seen steady growth, collaborating with 58 insurance companies to launch 294 health insurance products, with insurance technology service revenue reaching 99.44 million yuan in the first half of 2025 [3] Group 4: User Base and Engagement - As of June 2025, the company has accumulated 168.4 million registered users, with 60.4% belonging to the core health consumer group aged 20-45 [4] - The user retention rate after 13 months is 92.2%, significantly higher than the industry average, indicating strong user loyalty [4] - The conversion rate of active users to policyholders improved from 5.0‰ to 6.7‰ between 2024 and the first half of 2025, reflecting high user satisfaction with the platform's services [4] Group 5: AI Integration and Ecosystem Development - The company's core competitiveness stems from the deep integration of AI technology across various business scenarios, with its self-developed AIcare technology stack applied in multiple core areas [5] - The contribution of AI models to annualized premium value increased from 1.5% in 2022 to 23.3% in 2024, maintaining a high level of 21.3% in the first half of 2025 [5] - The introduction of the generative AI tool "Qingsong Ask Doctor Dr.GPT" in 2023 has expanded the application of AI in health services, enhancing user experience and supporting healthcare professionals [5] Group 6: Market Opportunities and Future Outlook - The IPO coincides with a golden development period for China's digital health industry, supported by increasing health awareness and favorable policies [6] - The market for comprehensive health services and health insurance is projected to reach 11.8 trillion yuan by 2029, with a compound annual growth rate of 7.7% from 2024 to 2029 [6] - The funds raised from the IPO will be used to enhance AI technology, extend health service scenarios, and integrate industry resources, aiming to strengthen the "healthcare + medicine + pharmaceuticals + wellness + insurance" ecosystem [6] Group 7: Strategic Positioning - The IPO will provide Qingsong Health Group with ample funds and resources to accelerate ecosystem expansion and technology implementation, reinforcing its leading position in the industry [7] - With ongoing technology development, enriched service scenarios, and deep user value exploration, the company is poised to become a benchmark enterprise in China's digital health industry, offering long-term and stable value returns to investors [7]

Core Viewpoint - AI technology has become a significant growth engine for the company, which is positioned as a leading digital health and insurance service platform in China [4][5]. Group 1: IPO Details - The company officially listed on the Hong Kong Stock Exchange on December 23, 2025, under the stock code "2661" [2]. - A total of 26,540,000 shares were issued, with the Hong Kong public offering being oversubscribed by 1,421.47 times and the international offering by 2.9 times [2]. - The cornerstone investor, Guangdong Hengqin Guangdong-Macao Deep Cooperation Zone Aoqin Harmony Investment Partnership, subscribed for 100 million RMB [2]. Group 2: Financial Performance - As of 11:00 AM, the stock price reached HKD 53.40, representing an increase of over 135% from the issue price, with a market capitalization exceeding HKD 11 billion [3]. - Revenue figures for the company from 2022 to 2024 are projected to be 394 million RMB, 490 million RMB, and 945 million RMB, respectively, reflecting a compound annual growth rate (CAGR) of 54.9% [4]. - In the first half of this year, revenue grew by 84.7% year-on-year to 656 million RMB, with health service revenue accounting for 76.7% of total revenue [5]. Group 3: Market Position and User Base - The company ranks 10th in China's digital comprehensive health and health insurance market based on projected 2024 revenue, and 7th in the digital health service market [4]. - The total registered user base has reached 168.4 million, with 60.4% of users aged between 20 and 45, and a high user retention rate of 92.2% after 13 months [4]. Group 4: Strategic Focus - The funds raised from the IPO will primarily be used for AI technology upgrades, expansion of health service scenarios, and integration of the industry chain [5]. - The company aims to deepen the "testing-medical-pharmaceutical-health-insurance" ecosystem, leveraging the vast market potential of the digital health industry [5].

Core Viewpoint - The company "轻松健康" (Easy Health) has successfully listed its shares at a price of HKD 22.68, raising approximately HKD 513 million, with a significant initial trading increase of 120.46% to HKD 50 per share [1] Group 1: Company Overview - Easy Health provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research and public health knowledge [1] - The company aims to offer accessible, precise, and affordable health solutions to those in need [1] Group 2: Market Position - According to a report by Sullivan, Easy Health ranks 10th in China's digital integrated health services and health insurance market based on projected revenue for 2024, and 7th in the digital health services market [1] - The company was previously known as "轻松筹" (Easy Fundraising), a major online disease crowdfunding platform in mainland China, and rebranded to Easy Health Group in 2019 after obtaining an insurance brokerage license in 2016 [1]

Core Viewpoint - The digital health service provider, Easy Health (stock code: 02661.HK), made a strong debut on the Hong Kong Stock Exchange, opening at HKD 50, a significant increase of 120.46% from its issue price of HKD 22.68, reflecting high investor interest and demand [1][2]. Company Overview - Easy Health offers comprehensive digital health services and health insurance solutions in China, including disease screening promotion, health check consultation, medical appointment services, and health product sales, primarily reaching individual users through online platforms [3]. - According to a report by Sullivan, Easy Health ranks tenth in the Chinese digital comprehensive health services and health insurance market based on revenue for 2024, and seventh in the segmented digital health services market [3]. Financial Performance - The company's revenue has shown rapid growth, increasing from RMB 394 million in 2022 to RMB 945 million in 2024, representing a growth of over 140% within two years [3]. - Although the adjusted net profit fluctuated during this period, decreasing from RMB 149 million in 2022 to RMB 84 million in 2024, the financial data for the first half of 2025 indicates a recovery, with revenue reaching RMB 656 million and adjusted net profit at RMB 51 million [3].

财务数据同样亮眼，2024年公司营收同比增长92.9%至9.45亿元，2025年上半年营收再增84.7%至6.56亿 元，健康服务业务收入占比已达76.7%，成为绝对核心增长引擎。在当前港股新股市场分化加剧、稀缺 性标的受追捧的背景下，轻松健康集团凭借"AI技术+用户规模+业务闭环"的独特优势，成功吸引资金 聚焦，为后续股价表现奠定基础。保荐机构表示，公司所处赛道契合"健康中国"战略，未来增长确定性 强，有望成为港股数字健康板块的核心配置标的。 智通财经APP获悉，12月23日，国内"AI+健康"赛道标杆企业轻松健康集团(02661)正式登陆港交所主 板。受市场对数字健康赛道的强烈看好及公司基本面支撑，股价开盘即迎来强势表现，开盘价报50港 元，较发行价高开120%。 作为港股市场稀缺的"全链条数字健康"标的，轻松健康集团的亮眼表现源于多重核心优势。用户层面， 平台累计注册用户已达1.684亿，其中60.4%为20-45岁核心健康消费群体，用户基础为业绩增长提供坚 实支撑。技术层面，自主研发的AIcare技术栈已广泛应用于内容创作、智能承保、理赔审核等核心场 景，AI模型贡献的线索价值持续提升，技术赋能成效显 ...

12月22日，港股新股轻松健康集团(02661)暗盘交易正式启动，开盘即迎来强势拉升，延续招股阶段的 火爆热度。截至暗盘交易时段，公司股价较发行价大涨超110%，市值逼近百亿，成为近期港股暗盘市 场的亮眼标的。 据悉，轻松健康将于12月23日正式在香港联交所主板挂牌上市。本次IPO募资将重点用于AI技术升级、 健康服务场景拓展及产业链整合，持续深化"检-医-药-康-险"生态闭环。业内人士表示，在数字健康产 业万亿市场空间加持下，公司凭借稀缺商业模式与突出竞争优势，上市后有望持续受到资金关注，为投 资者带来长期回报。 暗盘交易作为港股新股正式上市前的场外交易环节，其表现被视为新股上市首日走势的重要风向标。轻 松健康暗盘的大幅高开，印证了资本市场对其"AI+全链条数字健康"模式的坚定信心。此前公司全球招 股超额认购倍数高达1421倍。 市场热度背后，是公司扎实的核心竞争力支撑。作为国内领先的综合数字健康平台，轻松健康累计注册 用户达1.684亿，60.4%为20-45岁核心消费群体，用户第13个月留存率高达92.2%。AI技术深度赋能全业 务链条，自研AIcare技术栈贡献线索价值占比超21%。同时，公司业务结构 ...

Group 1 - The core viewpoint of the article highlights the successful IPO of Easy Health (02661), which received a subscription of HKD 620.4 billion from brokers, resulting in an oversubscription of 1029.8 times against a public offering amount of HKD 60.19 million [1] - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company is expected to be listed on December 23, with CICC and China Merchants Securities International as joint sponsors [1] Group 2 - Easy Health, established in 2014, provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - According to a report by Sullivan, Easy Health ranks 10th in China's digital integrated health services and health insurance market based on projected revenue for 2024, and 7th in the digital health services market [1] - The company, formerly known as "Qing Song Chou," transitioned from being a major online disease crowdfunding platform to a health service provider, obtaining an insurance brokerage license in 2016 and rebranding in 2019 [1] Group 3 - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing a total investment of RMB 100 million, which translates to 4.8018 million shares at the offering price of HKD 22.68 per share [2] - Financial projections indicate that Easy Health expects revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025, respectively, with corresponding profits of RMB 73.616 million, RMB 10.398 million, and RMB 86.045 million [2] - The net proceeds from the fundraising will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The company, Easy Health (02661), has successfully completed its IPO subscription, raising significant interest with a total subscription amount of HKD 620.4 billion, leading to an oversubscription rate of 1029.8 times [1] Group 1: IPO Details - The company plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The minimum investment for one lot of shares (200 shares) is HKD 4,581.8, and the company is expected to be listed on December 23 [1] - CICC and China Merchants Securities International are the joint sponsors for the IPO [1] Group 2: Company Background - Easy Health Group was established in 2014, providing comprehensive health and insurance solutions, including early screening, health management, health insurance, and medical research support [1] - The company aims to offer accessible, precise, and affordable health solutions to those in need [1] - Originally known as "Qing Song Chou," the company transitioned to Easy Health Group in 2019, expanding its services across various sectors [1] Group 3: Financial Performance - For the fiscal years ending June 30, 2023, 2024, and 2025, the company reported revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million, respectively [2] - The corresponding profits for the same periods were RMB 73.62 million, RMB 10.40 million, and RMB 86.05 million [2] Group 4: Use of Proceeds - The net proceeds from the IPO will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The company, Easy Health (02661), has successfully completed its IPO subscription, raising significant interest with a total margin of HKD 62.04 billion and an oversubscription rate of 1029.8 times, indicating strong market demand for its shares [1] Group 1: IPO Details - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company anticipates its shares will begin trading on December 23, with CICC and China Merchants Securities International acting as joint sponsors [1] Group 2: Company Background - Established in 2014, Easy Health provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - The company ranks 10th in China's digital integrated health services and health insurance market, and 7th in the digital health services market according to a report by Sullivan [1] Group 3: Financial Information - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing RMB 100 million, which translates to approximately 4.80 million shares at the IPO price [2] - Projected revenues for Easy Health are approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025 respectively, with corresponding profits of RMB 73.62 million, RMB 10.40 million, and RMB 86.05 million [2] Group 4: Use of Proceeds - The net proceeds from the IPO will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]